Bank of America’s IO Biotech IOBT Stock Holding History

Bank of America’s Portfolio IOBT Stock Details IOBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-799,953	Closed	-$486K	–	6294
2025 Q4	$486K	Hold	799,953	–	–	﹤0.01%	4926
2025 Q3	$290K	Sell	799,953 -815,121	-50%	-$1.41M	﹤0.01%	6106
2025 Q2	$2.24M	Sell	1,615,074 -36,441	-2%	-$41.7K	﹤0.01%	4671
2025 Q1	$1.8M	Hold	1,651,515	–	–	﹤0.01%	4764
2024 Q4	$1.52M	Hold	1,651,515	–	–	﹤0.01%	4679
2024 Q3	$1.73M	Hold	1,651,515	–	–	﹤0.01%	4663
2024 Q2	$1.93M	Sell	1,651,515 -192,670	-10%	-$269K	﹤0.01%	4468
2024 Q1	$3.19M	Hold	1,844,185	–	–	﹤0.01%	4044
2023 Q4	$3.47M	Sell	1,844,185 -10,000	-0.5%	-$11.9K	﹤0.01%	3874
2023 Q3	$2.61M	Hold	1,854,185	–	–	﹤0.01%	4015
2023 Q2	$3.62M	Hold	1,854,185	–	–	﹤0.01%	3697
2023 Q1	$3.48M	Hold	1,854,185	–	–	﹤0.01%	3862
2022 Q4	$4.26M	Buy	1,854,185 +1,844,185	+18,442%	+$4.88M	﹤0.01%	3538
2022 Q3	$27K	Hold	10,000	–	–	﹤0.01%	6920
2022 Q2	$47K	Hold	10,000	–	–	﹤0.01%	6861
2022 Q1	$53K	Hold	10,000	–	–	﹤0.01%	7154
2021 Q4	$64K	Buy	+10,000	New	+$96.6K	﹤0.01%	7091

Other funds holding IOBT

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return

Bank of America's IOBT Position: Q1 2026 in Review

Bank of America sold out of IO Biotech (IOBT) in Q1 2026, closing a stake of 799,953 shares — an estimated $486K sold.

Bank of America first reported a position in IOBT in Q4 2021 and held it in 17 quarters. The position peaked at $4.26M in Q4 2022. 12 funds tracked by Wall St. Rank hold IOBT as of Q1 2026.

Bank of America reported no remaining IO Biotech position as of Q1 2026 after selling out during the quarter.
Bank of America sold 799,953 IO Biotech shares in Q1 2026, an estimated $486K.
Bank of America first reported a position in IO Biotech in Q4 2021 and held it in 17 quarters.
Bank of America's IO Biotech position peaked at $4.26M in Q4 2022.
12 funds tracked by Wall St. Rank held IO Biotech as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.